« Back

Alimera Sciences gets $30M for eye-disease drug – Alimera Sciences, an Alpharetta, Ga., drug developer with a focus on eye disease, raised $30 million in a third funding round. The company will now take a majority stake in its drug for diabetic macular edema, a vision-degrading complication of diabetes, which Alimera is developing with its partner pSividia. Alimera is presumably still contemplating an IPO this fall. All five of the company’s existing VC backers participated in the round: Scale Venture Partners, Domain Associates, Intersouth Partners, Polaris Venture Partners and Venrock Associates.

« Back